Corneal surgery in keratoconus: which type, which technique, which outcomes?
© Arnalich-Montiel et al. 2016
Received: 21 October 2015
Accepted: 9 January 2016
Published: 18 January 2016
Keratoconus is a disease characterized by progressive thinning, bulging, and distortion of the cornea. Advanced cases usually present with loss of vision due to high irregular astigmatism. A majority of these cases require surgical intervention. This review provides an update on the current treatment modalities of corneal surgery available for the management of advanced corneal ectasias.
KeywordsKeratoconus Deep anterior lamellar keratoplasty Penetrating keratoplasty Corneal transplant Rejection
Corneal graft is the traditional recourse for advanced keratoconus . There are many different grading schemes for keratoconus from scales based on outdated indices such as the Amsler-Krumeich scale, to scales using a variety of detailed metrics of corneal structure provided by anterior segment optical coherence tomography and Pentacam imaging. All these different scales do not always correlate well with disease impact. While there are eyes with milder disease that may exhibit contact lens intolerances, there are other eyes with severe disease that obtain good functional vision with contact lenses.
Therefore, although there is no precise definition for advanced disease, most specialists would agree that a keratoconus patient is eligible for corneal transplant when spectacle correction is insufficient, continued contact lens wear is intolerable, and visual acuity has fallen to unacceptable levels . Nevertheless, there has been a strong push to extend other treatment modalities that were originally meant for mild to moderate disease such as ultraviolet crosslinking (UV-CXL) and intrastromal corneal ring segments (ICRS) to treat advanced disease. In 2014, Bowman Layer transplantation was also described for advanced keratoconus with extreme thinning/steepening . These less troublesome therapeutic alternatives will seek to arrest disease progression, re-enable comfortable contact lens, or improve visual acuity to some extent, although rarely do the visual gains exceed one or two lines in advanced disease. These techniques would permit penetrating keratoplasty (PK) or deep anterior lamellar keratoplasty (DALK) to be postponed or avoided entirely .
In general, despite the excellent outcomes of PK, DALK may be preferred in patients with keratoconus because of the absence of risk of endothelial rejection, earlier tapering of steroids, decreased risk of secondary glaucoma, and increased wound strength . The advantage of DALK is even more evident in patients with mental retardation in which PK has a higher incidence of postoperative complications such as globe rupture, corneal ulceration and graft rejection, as well as in phakic patients, and corneas with significant peripheral thinning .
PK would be considered more suitable in cases where endothelial dysfunction is present or when deep corneal scarring severely affects the visual axis up to the Descemet membrane (DM) level. It is not unusual for keratoconus to coexist with endothelial dysfunction; it might be underestimated as stromal thinning of keratoconus may mask the corneal edema. Fuchs endothelial dystrophy is the most common of such disorders, but also include posterior polymorphous dystrophy, a peculiar condition of endothelial depletion and guttae excrescences that may be the product of the keratoconus itself rather than a distinct entity . If central deep corneal scarring is present, PK will provide a better visual acuity than DALK, but with a higher risk. In some instances, safety of DALK can outbalance the better visual acuity of PK. In fact, when corneal scars arise from previous hydrops, PK outcomes tend to be worse as the risk of graft rejection is higher . In these cases, manual lamellar dissection for DALK is a good choice as Anwar’s big bubble technique is contraindicated owing to the high risk of perforation during surgery.
A review of the literature on the topic of surgical treatment of keratoconus has received considerable attention and a formidable number and variety of surgical procedures even before keratoplasty was considered the most suitable procedure . Surgical options that have been proposed include intraocular operations such as paracentesis of the anterior chamber, lens extraction or needling, or deviation of the pupil by incarcerating the iris in a corneal incision to achieve a stenopeic slit-like pupil; cone excision procedures; or flattening techniques by scar formation, brought by cauterization of the conus with chemicals, electrocautery, high frequency current or by splitting the DM .
Before keratoplasty became an option, Alfred Appelbaum in 1936  stated concerning the surgical treatment of keratoconus, “Surgical intervention aims to produce flattening of the cornea in order to improve eyesight. When no degree of useful vision is obtained with the use of contact glasses, operative intervention may be considered – but no sooner. Only in cases of advanced or nearly hopeless conditions should the patient undergo operation. Most ophthalmologists agree with this. Too much cannot be expected of surgical treatment. At best, it gives a result far from ideal and none too lasting. The unsightliness which inevitably follows must be anticipated, and the appearance of the eye is always marred to some extent.”
Castroviejo, a Spanish ophthalmologist born in Logroño, Spain, performed the first PK for keratoconus in 1936  in the Columbia Presbyterian Medical Center in New York. Several years later in an article about keratoplasty for the treatment of keratoconus, he concluded that keratoplasty was the only surgical procedure that fulfilled the two essential requirements for treating keratoconus: surgery had to be limited to the cornea, and the whole corneal protrusion had to be removed and replaced with normal tissue of normal curvature and thickness, leaving the pupillary area free of scarring. Based on his experience, when a suitable technique was used, the percentage of permanently, greatly improved vision increased from 75 % to 90 % .
Lamellar keratoplasty (LK) was described earlier than PK. Although Arthur von Hippel performed the first successful LK in man in 1888  decades earlier than the first successful human PK by Edward Zinn, Von Hippel’s technique was abandoned in 1914 for PK and was not reintroduced until the 1940s . However, the concept of deep LK extending down to DM is relatively new. Gasset reported a series of keratoconus patients in the late 1970s who received full-thickness grafts stripped of DM transplanted into relatively deep lamellar beds, and enjoyed good surgical results with 80 % of cases achieving 20/30 or better vision . Dissection of host tissue ‘close to’ DM and the term ‘deep lamellar keratoplasty’ (DLK) in the conventional sense were first introduced by Archilla in 1984, who also showed the use of intrastromal air injection to opacify the cornea as a method to facilitate removal of host tissue . Sugita and Kondo reported the first extensive study on the results of DLK compared with PK in 1997 . They showed that postoperative visual acuity was similar between DLK and PK with no episodes of immunological rejection in over 100 eyes. Despite the clear benefits of DLK, the classical technique of removing stroma layer by layer was at that stage time-consuming and was greatly dependent on surgical experience. Only in the last two decades did DLK gain momentum thanks to improvement in surgical techniques and the availability of new surgical instruments and devices. The two most relevant papers on techniques were those from Melles and Anwar.
In 1999, Melles described a technique to visualize corneal thickness and dissection depth during surgery, which created an optical interface at the posterior corneal surface by filling the anterior chamber with air completely . In 2002, Anwar described his popular “big-bubble” technique in baring DM by injecting air into the deep stroma to create a large bubble between the stroma and DM .
Approximately about 12–20 % of the keratoconus patients may require a corneal transplantation . The Australian Graft Report of 2012 shows that keratoconus, with almost 1/3 of the corneal grafts performed, was the first reason for keratoplasty, followed by bullous keratoplasty and failed previous grafts. The 2012 Eye Banking statistical Report published by the Eye Banking Associations of America found that keratoconus was the reason for PK in 18 % of the cases and in 40 % of the DALK cases. Surprisingly, PK represented almost 80 % of the total grafts while DALK only accounted for 3 % of the total keratoplasties done, meaning that time-consuming and surgical experience is still a factor reducing the popularity of DALK in the US. Increasingly, however, DALK is becoming the preferred surgical option, largely thanks to improvements in operative technique, and now representing 10–20 % of all transplants for keratoconus and 30 % when eyes with previous hydrops are excluded . In the UK, the percentage of transplants for keratoconus in which DALK was used increased from 10 % in 1999–2000 to 35 % in 2007–2008 .
Penetrating keratoplasty in keratoconus
PK has traditionally been the surgery of choice for keratoconus, but nowadays lamellar techniques are the gold standard for patients with mild to moderate disease. Currently, an elective PK is reserved for those advanced cases where the DM and endothelium appear splitted due to a previous corneal hydrops. Frequently, a previous hydrops is not clearly reported by the patient, but in absence of an obvious endothelial split, deep stromal scars involving the DM are observed. In such cases a lamellar technique can still be attempted, mainly if these scars are not affecting the visual axis, but as the integrity of the DM is not intact any longer, this layer has a great tendency to rupture through the area of the scar (if and when a Big Bubble technique is used) and the surgery will need to be converted into a PK intraoperatively if a big tear is observed (longer than 2 to 3 clock hours).
A 7.5–8.5 mm host trephine (in relation with the corneal horizontal diameter) is often used and centered with the optical axis. However, the cone in keratoconus is often inferiorly displaced and should be fully removed to avoid residual or recurrent disease . Therefore, the extent of the cone should be well understood before surgery and thinning mapped out by slit lamp examination, as this will be difficult to discern with the operating microscope. Fleischer iron ring formation, which usually circumscribes the cone, may assist on its delineation. Corneal topography is not reliable in advanced scarred conus and should not be considered for surgical planning. Donor size will then be adjusted in relation with the host limbal white-to-white measurement and conus extension, so grafts larger than 8.5 mm may occasionally be needed in severe conus, as well as partial decentration respecting the optical axis in cases of very advanced conus with a severe thinning up to the perilimbal area. Yet, the risk of rejection increases with grafts larger than 8.5 mm in diameter and when the graft-host junction moves closer to the limbus, both of these which should be considered during post-operative treatment and management [18, 19]. Decentered grafts can as well induce a significant irregular astigmatism into the visual axis that requires rigid lenses for visual rehabilitation of the patient and occasionally, a second centered graft for visual purposes.
Once the four cardinal 10-0 nylon sutures have been placed, the surgeon can use any of these preferred suture techniques: interrupted sutures (IS), combined continuous and interrupted sutures (CCIS), single continuous suture (SCS) or double continuous suture (DCS). IS should always be the closure method of choice in cases where a partial or complete suture removal in one region of the graft is likely to be necessary at some point during the postoperative period, examples include: pediatric keratoplasty (sutures becoming loose too quickly), vascularization in the host cornea (occasionally seen after a hydrops episode or contact lens related keratitis), multiple previous rejections or other inflammatory concomitant conditions that may predispose to localized vascularization, rejection, or ulceration of the donor tissue. Furthermore, large and decentered grafts that are placed close to the limbal area present an increased risk of rejection, thus making the use of IS necessary for its closure.
IS, CCIS, and SCS have shown comparable postoperative astigmatism . In addition, a comparison of astigmatism in keratoconus patients utilizing a single continuous versus a DCS showed that after suture removal, astigmatism between the two groups was comparable (DCS − 4.6 D, SCS − 5.2 D) . Therefore, it is apparent that all methods of suture closure can work well. The ultimate choice rests with the surgeon.
PK offers good long-term visual rehabilitation for keratoconus patients. Compared with other indications for PK, there is a relatively low rate of graft failure and long mean graft survival. Rejection rate has been reported to be 5.8–41 % with a long term follow-up with most rejections occurring in the first 2 years [27–31]. Larger host trephine size, male donor gender, and non-white donor race have been associated with increased rejection hazard . Despite this observed rejection rate, only a 4–6.3 % graft failure rate has been reported with a mean follow-up of 15 years, and with an estimated 20 year probability of 12 % [27, 28, 32]. Fukoka et al. reported a cumulative probability of graft survival at 10, 20, and 25 years after PK of 98.8, 97.0 and 93.2 %, respectively, while Pramanik et al. estimated a graft survival rate of 85.4 % at 25 years after initial transplantation [28, 32]. Taken together, the existing evidence show that graft survival rate gradually decreases after 20 years post-PK.
An average best-corrected visual acuity (BCVA) in logarithm of the minimum angle of resolution (LogMAR) at preoperation, 10, 20, and 25 years after surgery of 1.54 ± 0.68, 0.06 ± 0.22, 0.03 ± 0.17, and 0.14 ± 0.42, respectively, have been reported . Best spectacle-corrected visual acuity (BSCVA) of 0.14 ± 0.11 LogMAR has been reported with a mean period of 33.5 months, while a BSCVA of 20/40 or better with a mean follow-up of 14 years was observed in 73.2 % of patients [31, 32].
An open angle glaucoma rate of 5.4 % with a mean follow-up of 14 years has also been reported .
Claesson et al. reported a poorer survival and worse visual outcome of regrafts compared with first grafts in patients where the original indication was keratoconus: the failure rate was three times higher with regrafts and the observed visual acuity with preferred correction was ≥ 0.5 in 69 % of first grafts while only 55 % of regrafts achieved that level .
Deep lamellar anterior keratoplasty in keratoconus
The goal of deep lamellar anterior keratoplasty in keratoconus is to achieve a depth of dissection as close as possible to DM. There are various ways to create a plane of separation between DM and the deep stromal layers mainly through variations of the two basic strategies: the Anwar big bubble method and the Melles manual dissection.
The big bubble method
Anwar based the big bubble method on a discovery in 1998 that intrastromal injection of balanced salt solution (BSS) was often effective at establishing cleavage plane just above DM . This takes advantage of the loose adhesion between DM and the posterior stroma. Anwar and Teichman later described the current big bubble procedure in 2002 using air instead of BSS .
Melles manual method
Over the years, there have been many variations to the standard technique. Lamellar dissection can be made with a diamond knife, nylon wire, microkeratome  or femtosecond laser. To help in guiding the dissection plane, trypan blue, ultrasound pachymetry  or real time optical coherence tomography  (OCT) has been used. Partharsathy et al. describe a “small bubble” technique for confirming the presence of the big bubble .
For corneas with extreme peripheral thinning, a modified procedure has been proposed dubbed “tuck-in lamellar keratoplasty” [39, 40]. In this technique, the central anterior stromal disc is removed and a centrifugal lamellar dissection is performed using a knife to create a peripheral intrastromal pocket extending 0.5 mm beyond the limbus. The donor cornea is prepared in such a way that it has a central full thickness graft with a peripheral partial thickness flange. The edges of a large anterior lamellar graft are tucked in below to add extra thickness.
Most studies have found equivalent visual and refractive results between PK and DALK, although 20/20 vision seems more likely after PK [16, 41], provided that stromal dissection reaches the level or close to the DM [16, 41–46]. For instance, in a recent study consisting Australian patients, which included 73 consecutive patients with keratoconus, the mean BCVA was not significantly different for DALK (0.14 logMAR, SD 0.2) versus PK (0.05 logMAR, SD 0.11) [16, 41]. A review of published literature that included 11 comparative studies on DALK and PK found that visual and refractive outcomes were comparable if the residual bed thickness in DALK cases were between 25 and 65 μm .
In studies where the visual outcomes of DALK where inferior to PK , the dissection plane was “pre-descemetic” and the incomplete stromal dissection and the not fully baring of the DM had a negative impact on the results . The problem seems to be related to the depth of the undissected stromal bed rather than to its smoothness as pre-descemetic DALKs performed by laser ablation did not outperform those dissected manually.
The recently published Australian graft registry data compared the outcomes of PKs and DALKs performed for keratoconus over the same period of time and found that overall, both graft survival and visual outcomes were superior for PK. In a recent study from the UK, Jones et al. compared the outcomes after PK and DALK for keratoconus . The risk of graft failure for DALK was almost twice that for PK. In day-to-day clinical practice, visual outcomes with DALK although comparable with PK, may be slightly inferior or less predictable compared with PK, given surgical inexperience, and unpredictable issues with respect to residual stromal thickness and DM folds. Nonetheless, elimination of risk of endothelial rejection compensates for this difference.
Lastly, one of the important advantages of DALK is a lower rate of endothelial loss compared with PK. The reported endothelial cell loss is as high as 34.6 % after PK, whereas for after DALK, cell loss was only 13.9 % .
Use of femtosecond laser in corneal graft for keratoconus
Allograft reactions are less frequent in DALK than in PK and less likely to result in graft failure if correct treatment is administered. Subepithelial and stromal rejection after DALK has been reported to be in the range of 3–14.3 % whereas in PK, it ranges from 13 to 31 % in the first 3 years after surgery . Endothelial rejection is not an issue in DALK.
Increases in intraocular pressure (IOP) following DALK has been reported in 1.3 % of operated eyes, compared with 42 % of eyes after PK . Development of glaucoma may also be up to 40 % less than PK ; it is attributed to the lower steroid requirement of DALK .
Urretz-Zavalia Syndrome was first reported following PK in keratoconus. It causes fixed, dilated pupil with iris atrophy that is a rare entity following DALK .
There are also a few complications that are unique to DALK and the presence of a donor-host interface. One of the major problems with DALKs is intraoperative DM perforation, which may occur in 0–50 % of the eyes , which has also been described to occur weeks after an uneventful surgery . Surgeon’s inexperience, corneal scarring near the DM, and advanced ectasias with corneal thickness less than 250 μm increase this risk [54, 55]. Depending on the size of the perforation, conversion to PK may be required to avoid double anterior chamber and persistent corneal edema, especially when the rupture leads to the collapse of the anterior chamber (macroperforation). Incidence of pseudo anterior chamber or double anterior chamber is in the range of 1 % . It can occur because of retention of fluid secondary to breaks in the DM or because of incomplete removal of viscoelastic in the interface . Large pseudo chambers must be managed surgically by drainage of the fluid and anterior chamber injection of air or gas , while small pseudo chambers normally end up resolving spontaneously . The presence of DM folds caused by a mismatch between donor button and the recipient bed is usually transient and would disappear over time, but interface wrinkling when central and persistent may affect quality of vision . Occasionally, an eye with an anatomically correct DALK may require a secondary reoperation to interface haze and poor visual acuity, usually stemming from incomplete or pre-descemetic stromal dissection . Interface keratitis is a serious complication of DALK and its caused mainly by Candida , but Klebsiella pneumonia  and nontuberculous mycobacteria  have also been isolated in several cases. Conservative treatment is usually unsuccessful and most cases need a therapeutic PK . Interface vascularization can occur because of inflammatory, infective, and traumatic episodes which can be treated with bevacizumab injection .
Keratoconus recurrence after corneal transplantation
It is well known how other corneal stromal dystrophies such as granular or lattice dystrophy tend to recur into the donor cornea due to either colonization of the new stroma by the abnormal host keratocytes or epithelial secretion in the early stages. In keratoconus, this host keratocyte invasion has not been well proven to be the main etiology for the post graft recurrent ectasia, but is likely to be related to the early keratoconic changes observed in the histology of explanted donor buttons after regrafting [65–67]. Post-graft ectasia is often preceded by thinning of the recipient stroma at the graft-host junction, so disease progression at the host stroma is likely to be the underlying reason for these cases of recurrent ectasia and progressive astigmatism [17, 65]. In such cases, a mean keratometric sphere and cylinder increase of 4D and 3D, respectively, between final suture removal and diagnosis can be observed .
The management of recurrent ectasia after corneal grafting should be spectacle adjustment if low astigmatism levels are induced, and rigid/hybrid gas permeable contact lenses with higher levels of astigmatism or significant anisometropia. For more advanced cases, scleral lenses may be considered before a surgical approach. If a second corneal transplant is required, either a new full thickness PK versus LK can be considered. Large grafts are usually necessary as the whole area of thinning should be included within the graft limits in order to excise the whole cone to avoid a new recurrence and also to avoid suturing through a thin recipient cornea. As large grafts are associated with increased risk of rejection and glaucoma, lamellar techniques by manual dissection of the host and donor corneal stroma are always preferable as far as the donor endothelium presents healthy without signs of failure. If femtosecond dissection of the lamellar bed is chosen, gentian violet and cyanoacrylate glue can be used in the area of thinning as masking agents to minimize the risk of perforation . Limbus may have to be recessed while suturing very large grafts that sit close to the limbus in order to avoid passing the suture through the host’s conjunctiva. Recurrence after regrafting has also been reported, so much so that it may require a third graft for visual rehabilitation .
Keratoconus recurrence after DALK has not been described. Very little evidence about its real incidence and impact is currently available. Feizi et al. reported a case where keratoconus recurred only 49 months after DALK . They suggested that the time interval from transplantation to recurrence may be shorter after DALK than after PK, but this has not been supported or confirmed by other authors . Further studies analyzing the long term outcomes after DALK for keratoconus is required in order to assess its impact .
A glance into the future
Keratoconus is a corneal disease that primarily affects the corneal stroma and Bowman’s layer. Current research and future therapeutic directions are focusing on the regeneration of corneal stroma by little to no invasive procedures to avoid the common complications that we still see even with LK techniques.
In the last few years, various studies have shown that CXL may offer some promise in slowing the progression of the disease [71, 72]. New modalities of CXL are being explored to improve the outcomes. CXL along with topography-guided photorefractive keratectomy (PRK) in order to provide better visual rehabilitation in patients with keratoconus is already being used . A novel approach to enhance riboflavin penetration is based on iontophoresis, a non-invasive system aimed to enhance the delivery of charged molecules into tissues using a small electric current. It has been shown that an iontophoresis imbibition lasting 5 min achieves a sufficient riboflavin concentration in the corneal stroma for CXL treatment, with the advantage of shortening the imbibition time while preserving epithelial integrity . Accelerated CXL was introduced in clinical practice in order to shorten the time required for a CXL procedure . This technique is based on the Bunsen-Roscoe law of photochemical reciprocity. That is, the same photochemical effect can be achieved with reducing the irradiation interval provided that the total energy level is kept constant by a corresponding increase in irradiation intensity. In this modality, pulsed accelerated corneal collagen crosslinking seems to be more effective than continuous light accelerated corneal collagen crosslinking .
Melles at al. recently described a new technique where an isolated Bowman’s layer is transplanted into a mid-stromal manually dissected corneal pocket in patients with an advanced (Stage III-IV) keratoconus . They observed a modest improvement in the maximum keratometry and BSCVA, but an unchanged best contact lens corrected visual acuity (BCLVA). This is a new and interesting approach that could have its indication for those advanced keratoconus unsuitable for corneal collagen crosslinking or intracorneal ring segments and intolerant to contact lenses, but without visually significant corneal scars and therefore good BCLVA. In such cases, Bowman’s transplant could avoid or postpone the necessity of keratoplasty if the mild observed corneal flattening enables continued contact lens wear and the cone is stabilized (as it has been reported to happen, but only with a sample of 20 eyes and a short mean follow-up of 21 months). Further research by alternative authors with a larger sample and longer follow up is needed before introducing this technique into routine clinical practice.
Intrastromal injection of stem cells alone:
Intrastromal implantation of stem cells together with a biodegradable scaffold:
Intrastromal implantation of stem cells with a non-biodegradable scaffold:
Intrastromal implantation of stem cells with a decellularized corneal stromal scaffold:
Treatment of keratoconus has experienced great advances in the last two decades. From being limited only to rigid gas permeable contact lens wear and PK for the most advanced cases, to having different therapeutic alternatives currently to treat not only the cone and postpone/avoid the necessity of a corneal transplant, but also being able to halt the progression of the disease with a very high rate of efficacy and safety. Also, the advances in refractive surgery including surface corneal ablation treatments and phakic intraocular lenses have allowed a better management and visual rehabilitation of these patients after a corneal transplant is required, being able to achieve, in many cases, a 20/20 unaided vision. The future expected advances in transepithelial crosslinking, nanotechnology, and regenerative medicine predicts an exciting future in this field and we will be looking forward to updating these guidelines.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Alió JL, Vega-Estrada A, Sanz-Díez P, Peña-García P, Durán-García ML, Maldonado M. Keratoconus management guidelines. Intern J Keratoconus Ectatic Corneal Dis. 2015;4(1):1–39.View ArticleGoogle Scholar
- Parker JS, van Dijk K, Melles GR. Treatment options for advanced keratoconus: A review. Surv Ophthalmol. 2015;60(5):459–80.View ArticlePubMedGoogle Scholar
- van Dijk K, Parker J, Tong CM, Ham L, Lie JT, Groeneveld-van Beek EA, et al. Midstromal isolated Bowman layer graft for reduction of advanced keratoconus: a technique to postpone penetrating or deep anterior lamellar keratoplasty. JAMA Ophthalmol. 2014;132(4):495–501.View ArticlePubMedGoogle Scholar
- Reinhart WJ, Musch DC, Jacobs DS, Lee WB, Kaufman SC, Shtein RM. Deep anterior lamellar keratoplasty as an alternative to penetrating keratoplasty a report by the american academy of ophthalmology. Ophthalmology. 2011;118(1):209–18.View ArticlePubMedGoogle Scholar
- El-Agha MS, El Sayed YM, Harhara RM, Essam HM. Correlation of corneal endothelial changes with different stages of keratoconus. Cornea. 2014;33(7):707–11.View ArticlePubMedGoogle Scholar
- Castroviejo R. Keratoplasty for the treatment of keratoconus. Trans Am Ophthalmol Soc. 1948;46:127–53.PubMed CentralPubMedGoogle Scholar
- Appelbaum A. Keratoconus. Arch Ophthalmol. 1936;15(5):900–21.View ArticleGoogle Scholar
- Paufique L, Charleux J. Lamellar keratoplasty. In: Casey T, editor. Corneal grafting. London: Butterworth; 1972. p. 121–76.Google Scholar
- John T. History. In: John T, editor. Corneal endothelial transplant. New Delhi: Jaypee- Highlights; 2010. p. 143–57.Google Scholar
- Gasset AR. Lamellar keratoplasty in the treatment of keratoconus: conectomy. Ophthalmic Surg. 1979;10(2):26–33.PubMedGoogle Scholar
- Archila EA. Deep lamellar keratoplasty dissection of host tissue with intrastromal air injection. Cornea. 1984;3(3):217–8.PubMedGoogle Scholar
- Sugita J, Kondo J. Deep lamellar keratoplasty with complete removal of pathological stroma for vision improvement. Br J Ophthalmol. 1997;81(3):184–8.PubMed CentralView ArticlePubMedGoogle Scholar
- Melles GR, Lander F, Rietveld FJ, Remeijer L, Beekhuis WH, Binder PS. A new surgical technique for deep stromal, anterior lamellar keratoplasty. Br J Ophthalmol. 1999;83(3):327–33.PubMed CentralView ArticlePubMedGoogle Scholar
- Anwar M, Teichmann KD. Big-bubble technique to bare descemet’s membrane in anterior lamellar keratoplasty. J Cataract Refract Surg. 2002;28(3):398–403.View ArticlePubMedGoogle Scholar
- Jhanji V, Sharma N, Vajpayee RB. Management of keratoconus: current scenario. Br J Ophthalmol. 2011;95(8):1044–50.View ArticlePubMedGoogle Scholar
- Jones MN, Armitage WJ, Ayliffe W, Larkin DF, Kaye SB. NHSBT Ocular tissue advisory group and contributing ophthalmologists (OTAG Audit Study 5). Penetrating and deep anterior lamellar keratoplasty for keratoconus: a comparison of graft outcomes in the United kingdom. Invest Ophthalmol Vis Sci. 2009;50(12):5625–9.View ArticlePubMedGoogle Scholar
- de Toledo JA, de la Paz MF, Barraquer RI, Barraquer J. Long-term progression of astigmatism after penetrating keratoplasty for keratoconus: evidence of late recurrence. Cornea. 2003;22(4):317–23.View ArticlePubMedGoogle Scholar
- Sharif KW, Casey TA. Penetrating keratoplasty for keratoconus: complications and long-term success. Br J Ophthalmol. 1991;75(3):142–6.PubMed CentralView ArticlePubMedGoogle Scholar
- Tuft SJ, Gregory WM, Davison C. Bilateral penetrating keratoplasty for keratoconus. Ophthalmology. 1995;102(3):462–8.View ArticlePubMedGoogle Scholar
- Olson RJ. Variation in corneal graft size related to trephine technique. Arch Ophthalmol. 1979;97(7):1323–5.View ArticlePubMedGoogle Scholar
- Wilson SE, Bourne WM. Effect of recipient-donor trephine size disparity on refractive error in keratoconus. Ophthalmology. 1989;96(3):299–305.View ArticlePubMedGoogle Scholar
- Javadi MA, Mohammadi MJ, Mirdehghan SA, Sajjadi SH. A comparison between donor-recipient corneal size and its effect on the ultimate refractive error induced in keratoconus. Cornea. 1993;12(5):401–5.View ArticlePubMedGoogle Scholar
- Kuryan J, Channa P. Refractive surgery after corneal transplant. Curr Opin Ophthalmol. 2010;21(4):259–64.PubMedGoogle Scholar
- Lanier JD, Bullington Jr RH, Prager TC. Axial length in keratoconus. Cornea. 1992;11(3):250–4.View ArticlePubMedGoogle Scholar
- Javadi MA, Naderi M, Zare M, Jenaban A, Rabei HM, Anissian A. Comparison of the effect of three suturing techniques on postkeratoplasty astigmatism in keratoconus. Cornea. 2006;25(9):1029–33.View ArticlePubMedGoogle Scholar
- Solano JM, Hodge DO, Bourne WM. Keratometric astigmatism after suture removal in penetrating keratoplasty: double running versus single running suture techniques. Cornea. 2003;22(8):716–20.View ArticlePubMedGoogle Scholar
- Niziol LM, Musch DC, Gillespie BW, Marcotte LM, Sugar A. Long-term outcomes in patients who received a corneal graft for keratoconus between 1980 and 1986. Am J Ophthalmol. 2013;155(2):213–9.View ArticlePubMedGoogle Scholar
- Fukuoka S, Honda N, Ono K, Mimura T, Usui T, Amano S. Extended long-term results of penetrating keratoplasty for keratoconus. Cornea. 2010;29(5):528–30.View ArticlePubMedGoogle Scholar
- Choi JA, Lee MA, Kim MS. Long-term outcomes of penetrating keratoplasty in keratoconus: analysis of the factors associated with final visual acuities. Int J Ophthalmol. 2014;7(3):517–21.PubMed CentralPubMedGoogle Scholar
- Buzard KA, Fundingsland BR. Fundingsland, corneal transplant for keratoconus: results in early and late disease. J Cataract Refract Surg. 1997;23(3):398–406.View ArticlePubMedGoogle Scholar
- Javadi MA, Motlagh BF, Jafarinasab MR, Rabbanikhah Z, Anissian A, Souri H, et al. Outcomes of penetrating keratoplasty in keratoconus. Cornea. 2005;24(8):941–6.View ArticlePubMedGoogle Scholar
- Pramanik S, Musch DC, Sutphin JE, Farjo AA. Extended long-term outcomes of penetrating keratoplasty for keratoconus. Ophthalmology. 2006;113(9):1633–8.View ArticlePubMedGoogle Scholar
- Claesson M, Armitage WJ. Armitage, Clinical outcome of repeat penetrating keratoplasty. Cornea. 2013;32(7):1026–30.View ArticlePubMedGoogle Scholar
- Amayem AF, Anwar M. Fluid lamellar keratoplasty in keratoconus. Ophthalmology. 2000;107(1):76–9. discussion 80.View ArticlePubMedGoogle Scholar
- Bilgihan K, Ozdek SC, Sari A, Hasanreisoglu B. Microkeratome-assisted lamellar keratoplasty for keratoconus: stromal sandwich. J Cataract Refract Surg. 2003;29(7):1267–72.View ArticlePubMedGoogle Scholar
- Ghanem RC, Ghanem MA. Pachymetry-guided intrastromal air injection (“pachy-bubble”) for deep anterior lamellar keratoplasty. Cornea. 2012;31(9):1087–91.View ArticlePubMedGoogle Scholar
- De Benito-Llopis L, Mehta JS, Angunawela RI, Ang M, Tan DT. Intraoperative anterior segment optical coherence tomography: a novel assessment tool during deep anterior lamellar keratoplasty. Am J Ophthalmol. 2014;157(2):334–41. e3.View ArticlePubMedGoogle Scholar
- Parthasarathy A, Por YM, Tan DT. Use of a “small-bubble technique” to increase the success of Anwar’s “big-bubble technique” for deep lamellar keratoplasty with complete baring of descemet’s membrane. Br J Ophthalmol. 2007;91(10):1369–73.PubMed CentralView ArticlePubMedGoogle Scholar
- Vajpayee RB, Bhartiya P, Sharma N. Central lamellar keratoplasty with peripheral intralamellar tuck: a new surgical technique for keratoglobus. Cornea. 2002;21(7):657–60.View ArticlePubMedGoogle Scholar
- Kaushal S, Jhanji V, Sharma N, Tandon R, Titiyal JS, Vajpayee RB. “Tuck In” Lamellar Keratoplasty (TILK) for corneal ectasias involving corneal periphery. Br J Ophthalmol. 2008;92(2):286–90.View ArticlePubMedGoogle Scholar
- MacIntyre R, Chow SP, Chan E, Poon A. Long-term outcomes of deep anterior lamellar keratoplasty versus penetrating keratoplasty in Australian keratoconus patients. Cornea. 2014;33(1):6–9.View ArticlePubMedGoogle Scholar
- Fontana L, Parente G, Sincich A, Tassinari G. Influence of graft-host interface on the quality of vision after deep anterior lamellar keratoplasty in patients with keratoconus. Cornea. 2011;30(5):497–502.PubMedGoogle Scholar
- Funnell CL, Ball J, Noble BA. Noble, Comparative cohort study of the outcomes of deep lamellar keratoplasty and penetrating keratoplasty for keratoconus. Eye (Lond). 2006;20(5):527–32.View ArticleGoogle Scholar
- Smadja D, Colin J, Krueger RR, Mello GR, Gallois A, Mortemousque B. Outcomes of deep anterior lamellar keratoplasty for keratoconus: learning curve and advantages of the big bubble technique. Cornea. 2012;31(8):859–63.View ArticlePubMedGoogle Scholar
- Kim MH, Chung TY, Chung ES. A retrospective contralateral study comparing deep anterior lamellar keratoplasty with penetrating keratoplasty. Cornea. 2013;32(4):385–9.View ArticlePubMedGoogle Scholar
- Han DC, Mehta JS, Por YM, Htoon HM, Tan DT. Comparison of outcomes of lamellar keratoplasty and penetrating keratoplasty in keratoconus. Am J Ophthalmol. 2009;148(5):744–51. e1.View ArticlePubMedGoogle Scholar
- Ardjomand N, Hau S, McAlister JC, Bunce C, Galaretta D, Tuft SJ, et al. Quality of vision and graft thickness in deep anterior lamellar and penetrating corneal allografts. Am J Ophthalmol. 2007;143(2):228–35.View ArticlePubMedGoogle Scholar
- Zhang YM, Wu SQ, Yao YF. Long-term comparison of full-bed deep anterior lamellar keratoplasty and penetrating keratoplasty in treating keratoconus. J Zhejiang Univ Sci B. 2013;14(5):438–50.PubMed CentralView ArticlePubMedGoogle Scholar
- Shehadeh-Mashor R, Chan CC, Bahar I, Lichtinger A, Yeung SN, Rootman DS. Comparison between femtosecond laser mushroom configuration and manual trephine straight-edge configuration deep anterior lamellar keratoplasty. Br J Ophthalmol. 2014;98(1):35–9.View ArticlePubMedGoogle Scholar
- Tan DT, Anshu A, Parthasarathy A, Htoon HM. Visual acuity outcomes after deep anterior lamellar keratoplasty: a case–control study. Br J Ophthalmol. 2010;94(10):1295–9.View ArticlePubMedGoogle Scholar
- Musa FU, Patil S, Rafiq O, Galloway P, Ball J, Morrell A. Long-term risk of intraocular pressure elevation and glaucoma escalation after deep anterior lamellar keratoplasty. Clin Experiment Ophthalmol. 2012;40(8):780–5.View ArticlePubMedGoogle Scholar
- Niknam S, Rajabi MT. Fixed dilated pupil (urrets-zavalia syndrome) after deep anterior lamellar keratoplasty. Cornea. 2009;28(10):1187–90.View ArticlePubMedGoogle Scholar
- Romano V, Steger B, Kaye SB. Spontaneous descemet membrane tear after uneventful big-bubble deep anterior lamellar keratoplasty. Cornea. 2015;34(4):479–81.View ArticlePubMedGoogle Scholar
- Michieletto P, Balestrazzi A, Balestrazzi A, Mazzotta C, Occhipinti I, Rossi T. Factors predicting unsuccessful big bubble deep lamellar anterior keratoplasty. Ophthalmologica. 2006;220(6):379–82.View ArticlePubMedGoogle Scholar
- Baradaran-Rafii A, Eslani M, Sadoughi MM, Esfandiari H, Karimian F. Anwar versus Melles deep anterior lamellar keratoplasty for keratoconus: a prospective randomized clinical trial. Ophthalmology. 2013;120(2):252–9.View ArticlePubMedGoogle Scholar
- Sharma N, Jhanji V, Titiyal JS, Amiel H, Vajpayee RB. Use of trypan blue dye during conversion of deep anterior lamellar keratoplasty to penetrating keratoplasty. J Cataract Refract Surg. 2008;34(8):1242–5.View ArticlePubMedGoogle Scholar
- Sarnicola V, Toro P, Gentile D, Hannush SB. Descemetic DALK and predescemetic DALK: outcomes in 236 cases of keratoconus. Cornea. 2010;29(1):53–9.View ArticlePubMedGoogle Scholar
- Shimmura S, Tsubota K. Deep anterior lamellar keratoplasty. Curr Opin Ophthalmol. 2006;17(4):349–55.View ArticlePubMedGoogle Scholar
- Tu KL, Ibrahim M, Kaye SB. Spontaneous resolution of descemet membrane detachment after deep anterior lamellar keratoplasty. Cornea. 2006;25(1):104–6.View ArticlePubMedGoogle Scholar
- Mohamed SR, Manna A, Amissah-Arthur K, McDonnell PJ. Non-resolving Descemet folds 2 years following deep anterior lamellar keratoplasty: the impact on visual outcome. Cont Lens Anterior Eye. 2009;32(6):300–2.View ArticlePubMedGoogle Scholar
- Kanavi MR, Foroutan AR, Kamel MR, Afsar N, Javadi MA. Candida interface keratitis after deep anterior lamellar keratoplasty: clinical, microbiologic, histopathologic, and confocal microscopic reports. Cornea. 2007;26(8):913–6.View ArticlePubMedGoogle Scholar
- Zarei-Ghanavati S, Sedaghat MR, Ghavami-Shahri A. Acute Klebsiella pneumoniae interface keratitis after deep anterior lamellar keratoplasty. Jpn J Ophthalmol. 2011;55(1):74–6.View ArticlePubMedGoogle Scholar
- Murthy SI, Jain R, Swarup R, Sangwan VS. Recurrent non-tuberculous mycobacterial keratitis after deep anterior lamellar keratoplasty for keratoconus. BMJ Case Rep. 2013;2013. doi: https://doi.org/10.1136/bcr-2013-200641
- Hashemian MN, Zare MA, Rahimi F, Mohammadpour M. Deep intrastromal bevacizumab injection for management of corneal stromal vascularization after deep anterior lamellar keratoplasty, a novel technique. Cornea. 2011;30(2):215–8.View ArticlePubMedGoogle Scholar
- Patel SV, Malta JB, Banitt MR, Mian SI, Sugar A, Elner VM, et al. Recurrent ectasia in corneal grafts and outcomes of repeat keratoplasty for keratoconus. Br J Ophthalmol. 2009;93(2):191–7.View ArticlePubMedGoogle Scholar
- Bourges JL, Savoldelli M, Dighiero P, Assouline M, Pouliquen Y, BenEzra D, et al. Recurrence of keratoconus characteristics: a clinical and histologic follow-up analysis of donor grafts. Ophthalmology. 2003;110(10):1920–5.View ArticlePubMedGoogle Scholar
- Brookes NH, Niederer RL, Hickey D, McGhee CN, Sherwin T. Recurrence of keratoconic pathology in penetrating keratoplasty buttons originally transplanted for keratoconus. Cornea. 2009;28(6):688–93.View ArticlePubMedGoogle Scholar
- Dang TQ, Molchan RP, Taylor KR, Reilly CD, Panday VA, Caldwell MC. Novel approach for the treatment of corneal ectasia in a graft. Cornea. 2014;33(3):310–2.PubMedGoogle Scholar
- Feizi S, Javadi MA, Rezaei KM. Recurrent keratoconus in a corneal graft after deep anterior lamellar keratoplasty. J Ophthalmic Vis Res. 2012;7(4):328–31.PubMed CentralPubMedGoogle Scholar
- Romano V, Iovieno A, Parente G, Soldani AM, Fontana L. Long-term clinical outcomes of deep anterior lamellar keratoplasty in patients with keratoconus. Am J Ophthalmol. 2015;159(3):505–11.View ArticlePubMedGoogle Scholar
- Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620–7.View ArticlePubMedGoogle Scholar
- Raiskup F, Theuring A, Pillunat LE, Spoerl E. Corneal collagen crosslinking with riboflavin and ultraviolet-a light in progressive keratoconus: ten-year results. J Cataract Refract Surg. 2015;41(1):41–6.PubMedGoogle Scholar
- Kanellopoulos AJ, Binder PS. Collagen cross-linking (CCL) with sequential topography-guided PRK: a temporizing alternative for keratoconus to penetrating keratoplasty. Cornea. 2007;26(7):891–5.View ArticlePubMedGoogle Scholar
- Vinciguerra P, Randleman JB, Romano V, Legrottaglie EF, Rosetta P, Camesasca FI, et al. Transepithelial iontophoresis corneal collagen cross-linking for progressive keratoconus: initial clinical outcomes. J Refract Surg. 2014;30(11):746–53.View ArticlePubMedGoogle Scholar
- Ziaei M, Barsam A, Shamie N, Vroman D, Kim T, Donnenfeld ED, et al. Reshaping procedures for the surgical management of corneal ectasia. J Cataract Refract Surg. 2015;41(4):842–72.View ArticlePubMedGoogle Scholar
- Mazzotta C, Traversi C, Caragiuli S, Rechichi M. Pulsed vs continuous light accelerated corneal collagen crosslinking: in vivo qualitative investigation by confocal microscopy and corneal OCT. Eye (Lond). 2014;28(10):1179–83.View ArticleGoogle Scholar
- van Dijk K, Liarakos VS, Parker J, Ham L, Lie JT, Groeneveld-van Beek EA, et al. Bowman layer transplantation to reduce and stabilize progressive, advanced keratoconus. Ophthalmology. 2015;122(5):909–17.View ArticlePubMedGoogle Scholar
- De Miguel MP, Alio JL, Arnalich-Montiel F, Fuentes-Julian S, de Benito-Llopis L, Amparo F, et al. Cornea and ocular surface treatment. Curr Stem Cell Res Ther. 2010;5(2):195–204.View ArticlePubMedGoogle Scholar
- Arnalich-Montiel F, Pastor S, Blazquez-Martinez A, Fernandez-Delgado J, Nistal M, Alio JL, et al. Adipose-derived stem cells are a source for cell therapy of the corneal stroma. Stem Cells. 2008;26(2):570–9.View ArticlePubMedGoogle Scholar
- Du Y, Carlson EC, Funderburgh ML, Birk DE, Pearlman E, Guo N, et al. Stem cell therapy restores transparency to defective murine corneas. Stem Cells. 2009;27(7):1635–42.PubMed CentralView ArticlePubMedGoogle Scholar
- Liu H, Zhang J, Liu CY, Wang IJ, Sieber M, Chang J, et al. Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null mice. PLoS One. 2010;5(5):e10707.PubMed CentralView ArticlePubMedGoogle Scholar
- Coulson-Thomas VJ, Caterson B, Kao WW. Transplantation of human umbilical mesenchymal stem cells cures the corneal defects of mucopolysaccharidosis VII mice. Stem Cells. 2013;31(10):2116–26.View ArticlePubMedGoogle Scholar
- Espandar L, Bunnell B, Wang GY, Gregory P, McBride C, Moshirfar M. Adipose-derived stem cells on hyaluronic acid-derived scaffold: a new horizon in bioengineered cornea. Arch Ophthalmol. 2012;130(2):202–8.View ArticlePubMedGoogle Scholar
- Ma XY, Bao HJ, Cui L, Zou J. The graft of autologous adipose-derived stem cells in the corneal stromal after mechanic damage. PLoS One. 2013;8(10):e76103.PubMed CentralView ArticlePubMedGoogle Scholar
- Ruberti JW, Zieske JD. Prelude to corneal tissue engineering - gaining control of collagen organization. Prog Retin Eye Res. 2008;27(5):549–77.PubMed CentralView ArticlePubMedGoogle Scholar
- Hu X, Lui W, Cui L, Wang M, Cao Y. Tissue engineering of nearly transparent corneal stroma. Tissue Eng. 2005;11(11–12):1710–7.View ArticlePubMedGoogle Scholar
- Alió del Barrio JL, Chiesa M, Gallego Ferrer G, Garagorri N, Briz N, Fernandez-Delgado J, et al. Biointegration of corneal macroporous membranes based on poly(ethyl acrylate) copolymers in an experimental animal model. J Biomed Mater Res A. 2015;103(3):1106–18.View ArticlePubMedGoogle Scholar
- Lynch AP, Ahearne M. Strategies for developing decellularized corneal scaffolds. Exp Eye Res. 2013;108:42–7.View ArticlePubMedGoogle Scholar
- Wilson SE, Liu JJ, Mohan RR. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res. 1999;18(3):293–309.View ArticlePubMedGoogle Scholar
- Choi JS, Williams JK, Greven M, Walter KA, Laber PW, Khang G, et al. Bioengineering endothelialized neo-corneas using donor-derived corneal endothelial cells and decellularized corneal stroma. Biomaterials. 2010;31(26):6738–45.View ArticlePubMedGoogle Scholar
- Shafiq MA, Gemeinhart RA, Yue BY, Djalilian AR. Decellularized human cornea for reconstructing the corneal epithelium and anterior stroma. Tissue Eng Part C Methods. 2012;18(5):340–8.PubMed CentralView ArticlePubMedGoogle Scholar
- Gonzalez-Andrades M, de la Cruz CJ, Ionescu AM, Campos A, Del Mar PM, Alaminos M. Generation of bioengineered corneas with decellularized xenografts and human keratocytes. Invest Ophthalmol Vis Sci. 2011;52(1):215–22.View ArticlePubMedGoogle Scholar
- del Barrio JL A, Chiesa M, Garagorri N, Garcia-Urquia N, Fernandez-Delgado J, Bataille L, et al. Acellular human corneal matrix sheets seeded with human adipose-derived mesenchymal stem cells integrate functionally in an experimental animal model. Exp Eye Res. 2015;132:91–100.View ArticleGoogle Scholar